Abstract: A cleansing bar composition comprising at least one cleanser chosen from soap and surfactant; taurine, in free or salt form; and one or more hydrophobic stabilizing agents. The hydrophobic stabilizing agent prevents the crystallization of taurine on the surface of the cleansing bar. Also methods of making the cleansing bar to inhibit crystallization of taurine in a cleansing bar.

Abstract: Described herein are oral care compositions comprising an effective amount of aluminum chlorohydrate suspended in a carrier for preventing, reducing or inhibiting dentinal hypersensitivity, the aluminum chlorohydrate exhibiting a SEC chromatogram having a SEC Peak 4 to Peak 3 intensity ratio of at least 7 and a Peak 4 intensity greater than a Peak 5 intensity; and methods of using the same.

Abstract: The present disclosure relates to methods for characterizing and diagnosing dental diseases. In particular, the present disclosure relates to methods for characterizing and diagnosing dental disease (e.g., gingivitis and periodontal disease) based on levels of AI-2 in oral fluids and plaque.

Abstract: Described herein, are compositions comprising a soluble quaternary ammonium polymer/polyphosphate complex made by combining ingredients comprising a quaternary ammonium polymer and polyphosphates having 2 or more phosphate units. Methods of making and using these compositions are also described.

Abstract: Described herein are oral care compositions comprising an effective amount of an enzyme cocktail, wherein the enzyme cocktail comprises an alkaline protease and a second enzyme selected from cellulose, ?-glucanase, and combinations thereof, in an orally acceptable carrier, together with methods of making and using the same.

Abstract: Aqueous and substantially non-aqueous oral compositions comprising a cationic steroidal compound are suitable for treating conditions of the oral cavity.

Abstract: Described herein are oral care compositions comprising (i) an orally acceptable gallium salt and (ii) a basic amino acid polymer, in amounts effective to disrupt biofilm; and methods of making and using the same.

Abstract: The present disclosure relates to compositions and methods for destabilizing biofilms, altering biofilm 3D structure, and dispersing biofilms, in order to enhance biofilm cell removal and/or sensitivity to other agents (e.g., environmental or co-applied treatments). In particular, the present disclosure relates to the use of L-arginine in the removal and/or sensitization (e.g., to antimicrobials) of microorganisms in medical, industrial, domestic, or environmental applications, as well as treatment of bacterial infections (e.g., in biofilms).

Abstract: This, intention relates to methods of assessing the bioflora of the mouth and of providing appropriate treatment utilizing a basic amino acid in accordance with the assessment.

Abstract: Aqueous oral compositions containing a cationic steroidal compound and a quaternary ammonium compound are suitable for treating conditions of the oral cavity.

Abstract: Oral care compositions and methods are described in which the composition includes a chalcone color change component, which may be phenyl-3-methoxy-4-hydroxystyryl ketone. The color change component is induced to change colors by addition of saliva and/or by a change in pH of the composition. The composition and methods provide benefits including providing visual cues to the user.

Abstract: Described herein are aqueous oral compositions comprising cationic steroidal compound and a quaternary ammonium compound; and methods for making and using the same.

Abstract: Described herein are oral care compositions comprising an effective amount of aluminum chlorohydrate suspended in a carrier for preventing, reducing or inhibiting dentinal hypersensitivity, the aluminum chlorohydrate exhibiting a SEC chromatogram having a SEC Peak 4 to Peak 3 intensity ratio of at least 7 and a Peak 4 intensity greater than a Peak 5 intensity; and methods of using the same.

Abstract: Compounds are described that are effective in enhancing the efficacy of antimicrobial agents. Also described are methods of using such compounds and compositions that include such compounds. The composition includes a chalcone compound and, optionally, an antimicrobial agent.

Abstract: Described herein are compositions comprising a quinone and one or more antibacterial agents, and methods of preparing and using the same.

Abstract: Disclosed are oral care compositions and the use of such oral care compositions for treating conditions caused by biofilm formation. Also disclosed are methods for inhibiting biofilm formation and/or degrading biofilm. The oral care composition includes a sesquiterpenoid and an antimicrobial agent, in which the sesquiterpenoid and the antimicrobial agent are present in an amount effective to inhibit and/or degrade a biofilm in the oral cavity.

Abstract: Described herein are oral care compositions comprising an effective amount of an enzyme cocktail, wherein the enzyme cocktail comprises an alkaline protease and a second enzyme selected from cellulase, ?-glucanase, and combinations thereof, in an orally acceptable carrier, together with methods of making and using the same.

Abstract: Described herein are aqueous oral compositions comprising cationic steroidal compound and a quaternary ammonium compound; and methods for making and using the same.

Abstract: Described herein are aqueous and substantially non-aqueous oral compositions comprising a cationic steroidal compound and methods of making and using the same.

Abstract: Disclosed are oral care compositions and the use of such oral care compositions for treating conditions caused by biofilm formation. Also disclosed are methods for inhibiting biofilm formation and/or degrading biofilm. The oral care composition includes a sesquiterpenoid and an antimicrobial agent, in which the sesquiterpenoid and the antimicrobial agent are present in an amount effective to inhibit and/or degrade a biofilm in the oral cavity.